Polk R E, Smith J E, Ducey K, Lower R R
Antimicrob Agents Chemother. 1982 Aug;22(2):201-3. doi: 10.1128/AAC.22.2.201.
This study compared the penetration of moxalactam and cefazolin into the human atrial appendage after simultaneous administration of both drugs by two routes. Nineteen adult patients scheduled for coronary vein bypass surgery randomly received 10 mg of moxalactam and cefazolin per kg by either the intramuscular or intravenous (bolus) route on administration of anesthesia. Concentrations of cefazolin in serum were significantly greater than concentrations of moxalactam at all times for both routes of administration. There were no significant differences, however, in the concentration of these drugs in atrial appendages, although concentrations of both agents administered intravenously were significantly greater than of drugs administered intramuscularly. (19.3 +/- 10.3 and 21.0 +/- 11.0 micrograms intravenously versus 8.3 +/- 3.6 and 10.1 +/- 3.2 micrograms/g intramuscularly for moxalactam and cefazolin, respectively).
本研究比较了通过两种途径同时给予莫西拉坦和头孢唑林后,它们在人心脏心耳中的渗透情况。19例计划进行冠状动脉搭桥手术的成年患者在麻醉给药时,通过肌肉注射或静脉注射(推注)途径随机接受每千克10毫克的莫西拉坦和头孢唑林。两种给药途径在所有时间点,血清中头孢唑林的浓度均显著高于莫西拉坦的浓度。然而,这些药物在心耳中的浓度没有显著差异,尽管静脉注射给药的两种药物浓度均显著高于肌肉注射给药的浓度。(莫西拉坦和头孢唑林静脉注射分别为19.3±10.3和21.0±11.0微克,肌肉注射分别为8.3±3.6和10.1±3.2微克/克)